iBio enters into $10 million common stock purchase agreement with Aspire Capital
iBio announced a common stock purchase agreement with Aspire Capital Fund. Within two business days of approval of the transaction by the NYSE MKT, Aspire Capital will complete an initial purchase of 1,136,354 shares of common stock at $0.44 per share. August 26, 2014